￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of domestic launch and medical insurance inclusion of ruxolitinib ointment

2026-02-01 22:25:32

Check Details
Ruxolitinib ointment is a new option for the treatment of atopic dermatitis and alopecia areata

2026-02-01 22:25:32

Check Details
Detailed explanation of applicable symptoms and efficacy of ruxolitinib ointment

2026-02-01 22:25:32

Check Details
How long should you take erlotinib hydrochloride?

2026-02-01 22:25:32

Check Details
How long does it take for erlotinib to take effect?

2026-02-01 22:25:32

Check Details
Feasibility analysis of the use of erlotinib in patients with HER2 gene mutations

2026-02-01 22:25:32

Check Details
Can dacomitinib be used if erlotinib is resistant?

2026-02-01 22:25:32

Check Details
What is the difference between erlotinib and crizotinib

2026-02-01 22:25:32

Check Details
What are the advantages of combining erlotinib with bevacizumab?

2026-02-01 22:25:32

Check Details
Can patients with lung adenocarcinoma be treated with erlotinib if there is no target?

2026-02-01 22:25:32

Check Details
How many platelets can one injection of Roprostim/Romigrastim increase?

2026-02-01 22:25:32

Check Details
Is loplastin/romilastin the most recommended?

2026-02-01 22:25:32

Check Details
Category
相关知识